We should highlight that in our study it was not possible to evaluate urinary albumin excretion and/or urinary albumin/creatinine ratio, and therefore the number of patients with metabolic syndrome may be underestimated according to the WHO criteria. This evidence concerns the gene ALB and metabolic syndrome.